µå·¯±×ÀÎÆ÷ ¾àǰ¿ä¾àÁ¤º¸ - ¸®µµ¿¡ÀÌÇ÷¯½ºÄ«Å¸Çö󽺸¶(¸®µµÄ«ÀÎ)
µå·°ÀÎÆ÷¸¦ ½ÃÀÛÆäÀÌÁö·Î   ·Î±×ÀΠȸ¿ø°¡ÀÔ ³»ÄÁÅÙÃ÷ÇÔ contacts
BIT Druginfo
  ½ÅÅëÇÕ°Ë»ö  
¾àǰ°Ë»ö|ÀÓºÎÅõ¿©|ATCºÐ·ùÄÚµå|ÀûÀÀÁõ|ÇѾà(»ý¾à)»çÁø|¾àÈ¿ºÐ·ù
¾àǰ°Ë»ö Á¦Ç°½Äº° »óÈ£ÀÛ¿ë ¼ººÐÁ¤º¸ ȯÀÚº¹¾àÁöµµ ¾àÁ¦ºñ½É»çÁöħ ÇàÀ§°ü·Ã½É»çÁöħ °Ô½ÃÆÇ Ä¿¹Â´ÏƼ
 
 
top
¾ÆÀ̵ðÀúÀå
line
ȸ¿ø°¡ÀÔ ¾ÆÀ̵ðºñ¹Ð¹øÈ£Ã£±â
·Î±ä¹®Á¦
bottom
¾àǰ°Ë»ö
¸®µµ¿¡ÀÌÇ÷¯½ºÄ«Å¸Çö󽺸¶
Çٽɿä¾àÁ¤º¸
¿ä¾àÁ¤º¸
»ó¼¼Á¤º¸
´ëü°¡´É/µ¿ÀϼººÐÀǾàǰ
»óÈ£ÀÛ¿ë
°ü·Ã¾àÈ¿ºÐ·ù
±âŸ ÇǺΠ& Á¡¸· °ü·Ã ¾à¹° (Other Skin & Mucous Membrane Related Agents)
°ü·Ã¾à¹°Ã£±â
ȯÀÚº¹¾àÁöµµ
¿ä¾à º¹¾à ¾È³»¹®
»ó¼¼ º¹¾à ¾È³»¹®
Á¦Çüº° º¹¾àÁöµµ
Á¦Ç°º° º¹¾àÁöµµ
Áúȯº° º¹¾àÁöµµ
Á¾ÇÕ º¹¾à ¾È³»¹®
¾àÁ¦ºñ½É»çÁöħ
Lidocaine ÆÐÃëÁ¦(ǰ¸í: ¸®µµÅ¾Ä«Å¸Çö󽺸¶)
½Å°æ°è(¸¶ÃëÁ¦, ÁøÅëÁ¦) ¹× ½Å±ÔµîÀç ½ÉÇ÷°ü°è ¾àÁ¦ Çã°¡»çÇ× Àü»ê½É»ç ¾È³»
½É»ç»ç·Ê
±âŸ °Ë»ö
ATC Äڵ庰
¼ººÐº°
ÀûÀÀÁõº°
º´¿ë±Ý±â ÀǾàǰ
ÀӺαݱâ ÀǾàǰ
ºñ¿ëÈ¿°úÀû ÇÔ·® ÀǾàǰ
ATCÄÚµå °Ë»ö
ÀûÀÀÁõ °Ë»ö
»ý¾à¸í °Ë»ö
Medline °Ë»ö
Lidocaine
My Drug Picture
My Drug List
¿ÀŸ½Å°í
bottom
Á¦Ç°ÄÚµå(KD)
Ç¥ÁØÄÚµå(¹ÙÄÚµå)
ǰ¸ñ±âÁØÄÚµå
bottom

ÇàÀ§Á¤ÀÇ+½É»çÁöħ
ÇàÀ§ Á¤ÀÇ
ÇàÀ§ ½É»çÁöħ
ÇàÀ§Á¤ÀÇ+½É»çÁöħ
ºÎ°¡Á¤º¸°Ë»ö
󹿻ç·Ê
ÀÌ»ó¹ÝÀÀ ¹× ´ëó¹ý
ÀÓ»êºÎ¸¦ À§ÇÑ
¿µ¾ç°ü¸®
ÀǾàǰ
¾ÈÀü»ç¿ë ¸Þ´º¾ó
KMLE ÀÇÇпë¾î
½º¸¶Æ®Æù
µå·°ÀÎÆ÷ ¸ð¹ÙÀÏ
bottom
 
 
 
   
¾àǰ°Ë»ö ¿ä¾àÁ¤º¸
 
 
¸®µµ¿¡ÀÌÇ÷¯½ºÄ«Å¸Çö󽺸¶(¸®µµÄ«ÀÎ)  LIDO A PLUS CATAPLASMA  
Àü¹®ÀǾàǰ | »èÁ¦
 
¾Ë¸²: µå·°ÀÎÆ÷¿¡¼­´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù.
īī¿À½ºÅ丮 Æ®À§ÅÍ ÆäÀ̽ººÏ Á¤º¸°¡ºÎÁ·ÇϽŰ¡¿ä?
Àü¹®/ÀÏ¹Ý Àü¹®
¾àǰ»çÁø
Èò»ö ¶Ç´Â ¹ÝÅõ¸íÇÑ Èò»öÀÇ Á¡Âø¼ºÀÇ °íü¸¦ ºÎÁ÷Æ÷ À§¿¡ µµÆ÷ÇÑ Æ¯À¯ÇÑ Çâ±â¸¦ °¡Áø īŸÇö󽺸¶Á¦
»çÁø»ó¼¼º¸±â  µ¿ÀϾà½Äº°»çÁø
ȸ¿øÁ¦°ø»çÁø
Á¦Á¶È¸»ç (ÁÖ)ºñ¾¾¿ùµåÁ¦¾à
ÆÇ¸Åȸ»ç (ÁÖ)ºñ¾¾¿ùµåÁ¦¾à
Çã°¡Á¤º¸
BIT ¾àÈ¿ºÐ·ù ±âŸ ÇǺΠ& Á¡¸· °ü·Ã ¾à¹° (Other Skin & Mucous Membrane Related Agents)
º¹ÁöºÎºÐ·ù 264[ÁøÅ롤Áø¾ç¡¤¼ö·Å¡¤¼Ò¿°Á¦ ]
û±¸ÄÚµå(KDÄÚµå)
   ºñ±Þ¿©Á¡°ËÄÚµå
653102320  
\0 ¿ø/1¸Å(2015.07.01)(ÇöÀç¾à°¡)
\1,066 ¿ø/1¸Å(2014.02.01) (º¯°æÀü¾à°¡)
ATCÄÚµå Lidocaine / N01BB02
NDCÄÚµå [Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
¼ººÐ / ÇÔ·® [½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

Lidocaine 700mg  Á¦Ç° °Ë»ö
÷°¡Á¦
 
  ¸¶À̵巯±×ÀúÀå ¸¶À̵巯±×µµ¿ò¸»

Çã°¡Á¤º¸ Á¤º¸¿ä¾à ÄÚµå ¹× ºÐ·ùÁ¤º¸ Á¦Ç°Á¤º¸ º¹¾àÁ¤º¸ ½É»çÁ¤º¸ ÇмúÁ¤º¸ »ç¿ëÀÚÄÁÅÙÃ÷ Àüü
À¯·áȸ¿ø °áÀç½Ã¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸¸¦ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù. À¯·áÁ¤º¸¸ñ·ÏÀº Àü¹®È¸¿øÀ¸·Î ·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
iconÇã°¡Á¤º¸
Ç׸ñ ³»¿ë
û±¸ÄÚµå(KDÄÚµå)
ºñ±Þ¿©Á¡°ËÄÚµå
»óÇѱݾ×
653102320   [º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸]
\0 ¿ø/1¸Å(2015.07.01)(ÇöÀç¾à°¡)
\1,066 ¿ø/1¸Å(2014.02.01)(º¯°æÀü¾à°¡)
[»óº´ÄÚµåÁ¶È¸]
[Áúº´ÄÚµåÁ¶È¸]
ºü¸¥Á¶È¸
¿ä¾àÁ¤º¸ [È¿´É] [¿ë¹ý] [±Ý±â] [½ÅÁßÅõ¿©] [ÀÌ»ó¹ÝÀÀ]
»ó¼¼Á¤º¸ [È¿´É] [¿ë¹ý] [°æ°í] [±Ý±â] [½ÅÁßÅõ¿©] [ÀÌ»ó¹ÝÀÀ] [ÀϹÝÁÖÀÇ] [»óÈ£ÀÛ¿ë] [ÀÓ»êºÎ] [¼öÀ¯ºÎ] [¼Ò¾Æ] [°í·ÉÀÚ] [½ÅÀå¾ÖȯÀÚ] [°£Àå¾ÖȯÀÚ] [Àû¿ëÁÖÀÇ] [°ú·®Åõ¿©] [ÀÓ»ó°Ë»çÄ¡] [º¸°ü] [±âŸ]
Á¦Ç°¼º»ó Èò»ö ¶Ç´Â ¹ÝÅõ¸íÇÑ Èò»öÀÇ Á¡Âø¼ºÀÇ °íü¸¦ ºÎÁ÷Æ÷ À§¿¡ µµÆ÷ÇÑ Æ¯À¯ÇÑ Çâ±â¸¦ °¡Áø īŸÇö󽺸¶Á¦  [Á¦ÇüÁ¤º¸ È®ÀÎ]
Æ÷À塤ÄÚµå´ÜÀ§
¾àǰ±Ô°Ý ´ÜÀ§ Æ÷ÀåÇüÅ ´ëÇ¥ÄÚµå Ç¥ÁØÄÚµå ºñ°í
700¹Ð¸®±×·¥ 5 ¸Å ÆÑ 8806531023202 8806531023219
ÁÖ¼ººÐÄÚµå 183806CPO   [µ¿ÀÏÇÑ ÁÖ¼ººÐÄڵ带 °¡Áø ¿À¸®Áö³¯ ¶Ç´Â Á¦³×¸¯ ÀǾàǰ Á¶È¸]
Çã°¡»çÇ× ¿ø¹®Á¶È¸ [Çã°¡»çÇ× ¿ø¹®Á¶È¸]
È¿´ÉÈ¿°ú [ÀûÀÀÁõ º° °Ë»ö]   
´ë»óÆ÷Áø ÈÄ ½Å°æÅëÁõ ¿ÏÈ­
¿ë¹ý¿ë·® * Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù.
   
[󹿾à¾î]

¼ºÀÎ : ÀÌ ¾àÀº 1ÀÏ 1ȸ 1 ~ 3¸Å ÃÖ´ë 12½Ã°£µ¿¾È »óó³ª ¼Õ»óÀÌ ¾ø´Â ÇǺο¡¼­ °¡Àå ÅëÁõÀÌ ½ÉÇÑ ºÎÀ§¿¡ ºÎÂøÇÑ´Ù.

ºÎÂø¹æ¹ý: ÀÌ ¾àÀº ¹ÐºÀÇÑ ÆÄ¿ìÄ¡¿¡¼­ ²¨³½ ÈÄ Áï½Ã ºÎÂøÇϵµ·Ï ÇÑ´Ù. °¡À§·Î ÀÛÀº Å©±â·Î ÀÚ¸¥ ÈÄ ¹Ú¸®(¹þ°Ü³»±â)Çʸ§À» Á¦°ÅÇÏ¿© »ç¿ëÇÒ ¼ö ÀÖ´Ù.

ÀÌ ¾àÀ» ±â·ÂÀÌ ¼èÇϰųª ¾à¹° ¼Ò½Ç(¾ø¾îÁü)¿¡ Àå¾Ö°¡ Àִ ȯÀÚ¿¡°Ô »ç¿ëÇÒ °æ¿ì, Á¼Àº ºÎÀ§¿¡¸¸ ºÙÀÌ´Â °ÍÀÌ ±ÇÀåµÈ´Ù.

ÇǺΠÀÚ±ØÀ̳ª ÀÛ¿­°¨(È­²ö°¨)ÀÌ ³ªÅ¸³¯ °æ¿ì, ÀÌ ¾àÀ» Á¦°ÅÇϰí ÀÚ±ØÀÌ ¾ø¾îÁú ¶§±îÁö ÀçºÎÂøÇÏÁö ¾Ê´Â´Ù.

ÀÌ ¾àÀ» ±¹¼Ò¸¶ÃëÁ¦¸¦ ÇÔÀ¯Çϰí ÀÖ´Â ´Ù¸¥ ¾àÁ¦¿Í ÇÔ²² »ç¿ëÇÒ °æ¿ì, ¸ðµç ¾àÁ¦·ÎºÎÅÍ Èí¼öµÇ´Â ±¹¼Ò¸¶ÃëÁ¦ÀÇ ÃÑ·®À» °í·ÁÇÏ¿©¾ß ÇÑ´Ù.

[BMIÁö¼ö °è»ê] [Body Surface Area °è»ê] [Cockcroft-Gault GFR °è»ê] [MDRD GFR °è»ê]
[°ú·®Åõ¿©½Ã ´ëó¹ý] [ÇÇÇØ¾ß ÇÒ À½½Ä] [º¹¿ëÀ» ÀØÀº °æ¿ì ´ëó¹ý]
±Ý±â

ÀÌ ¾à ¶Ç´Â ¾Æ¹Ìµå°è ±¹¼Ò¸¶ÃëÁ¦¿¡ °ú¹ÎÁõÀÌ Àִ ȯÀÚ

½ÅÁßÅõ¿©

ÀÌ ¾àÀº ÇǷξÆÈ²»ê³ªÆ®·ýÀÌ ÇÔÀ¯µÇ¾î ÀÖ¾î ¾Æ³ªÇʶô½Ã¿Í °°Àº ¾Ë·¹¸£±â¸¦ ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç ÀϺΠ°¨¼ö¼º ȯÀÚ¿¡¼­´Â »ý¸íÀ» À§ÇùÇÒ Á¤µµ ¶Ç´Â À̺¸´Ù ¾àÇÑ Ãµ½Ä¹ßÀÛÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Ù. ÀÏ¹Ý »ç¶÷¿¡¼­ÀÇ ¾ÆÈ²»ê°¨¼ö¼º¿¡ ´ëÇÑ ÃѰýÀûÀÎ ºóµµ´Â ¾Ë·ÁÁöÁö ¾Ê¾ÒÀ¸³ª ³·Àº °ÍÀ¸·Î º¸ÀÌ¸ç ¾ÆÈ²»ê°¨¼ö¼ºÀº ºñõ½ÄȯÀÚº¸´Ù õ½ÄȯÀÚ¿¡¼­ ºó¹øÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù.

ÀÌ ¾àÀº ÇÁ·ÎÇÊ·»±Û¸®ÄÝÀ» ÇÔÀ¯Çϰí ÀÖÀ¸¹Ç·Î ÀÌ ¼ººÐ¿¡ °ú¹ÎÇϰųª ¾Ë·¹¸£±â º´·ÂÀÌ Àִ ȯÀÚ¿¡´Â ½ÅÁßÈ÷ Åõ¿©ÇÑ´Ù.

ÀÌ»ó¹ÝÀÀ

1) ±¹¼Ò ÀÌ»ó¹ÝÀÀ

ÀÌ ¾à Àû¿ëºÎÀ§¿¡ ¼öÆ÷, ¸Û, ÀÛ¿­°¨(È­²ö°¨), Å»»ö¼Ò, ÇǺο°, º¯»ö, ºÎÁ¾(ºÎ±â), È«¹Ý(ºÓÀº ¹ÝÁ¡), ºñ´Ã, ÀÚ±Ø, ±¸Áø, Á¡ÃâÇ÷, °¡·Á¿ò, ¼ÒÆ÷(¹°Áý)°¡ »ý±â°Å³ª ÀÌ»ó °¨°¢ÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ÀÌ ¹ÝÀÀµéÀº ÀϹÝÀûÀ¸·Î °æ¹Ì(°¡º­¿î)Çϰųª ÀϽÃÀûÀ̸ç, ¼öºÐ~¼ö½Ã°£ ³»¿¡ ÀÚ¿¬ÀûÀ¸·Î ¼Ò½Ç(¾ø¾îÁü)µÈ´Ù.

2) ¾Ë·¹¸£±â ¹ÝÀÀ

µå¹°±â´Â ÇÏÁö¸¸, ÀÌ ¾à¿¡ ÀÇÇÑ ¾Ë·¹¸£±â ¹ÝÀÀ°ú ¾Æ³ªÇʶô½Ã½ºÀ¯»ç¹ÝÀÀÀÌ ÀϾ ¼ö ÀÖ´Ù. Áõ»óÀº Ç÷°üºÎÁ¾, ±â°üÁö¿¬Ãà, ÇǺο°, È£Èí°ï¶õ, °ú¹ÎÁõ, Èĵΰæ·Ã, °¡·Á¿ò, ¼îÅ©, µÎµå·¯±âÀ̸ç, Åë»óÀû ¹æ¹ýÀ¸·Î Ä¡·áµÉ ¼ö ÀÖ´Ù.

3) ±âŸ ÀÌ»ó¹ÝÀÀ

½ÃÆÇÈÄ Á¶»ç¿¡¼­ º¸°íµÈ Àΰú°ü°è°¡ ¹àÇôÁöÁö ¾ÊÀº ±âŸ ÀÌ»ó¹ÝÀÀÀº ´ÙÀ½°ú °°´Ù: ½Å°æ¼è¾àÁõ, Âø¶õ, ¹æÇâ°¨Àå¾Ö, ¾îÁö·³Áõ, µÎÅë, °¨°¢°ú¹Î, °¨°¢ ÀúÇÏ, Çö±âÁõ(¾îÁö·¯¿ò), ±Ý¼Ó¼º ¸À, ¿À½É(±¸¿ª), ºÒ¾È, ÅëÁõ, ¸¶ºñ, Á¹À½, ÀÔ¸Àº¯¼º, ±¸Åä, ½Ã°¢Àå¾Ö(½Ã¾ßÈ帲), È«Á¶, À̸í(±Í¿ï¸²), ÁøÀü(¶³¸²).

4) ¿ë·® °ü·Ã Àü½Å ÀÌ»ó¹ÝÀÀ

ÀÌ ¾àÀ» ÀûÀýÇÏ°Ô »ç¿ëÇßÀ» °æ¿ì, ¾à3%ÀÇ ¸®µµÄ«Àθ¸ Àü½ÅÀ¸·Î Èí¼öµÇ±â ¶§¹®¿¡, Àü½ÅÀÌ»ó¹ÝÀÀÀÌ °ÅÀÇ ³ªÅ¸³ªÁö ¾Ê´Â´Ù. ¸®µµÄ«ÀÎÀÇ Àü½ÅÀÌ»ó¹ÝÀÀÀº ÁßÃ߽Űæ°è ÈïºÐ ¹×/¶Ç´Â ¾ïÁ¦(Çö±âÁõ(¾îÁö·¯¿ò), ºÒ¾È, °ÆÁ¤, Çູ°¨, Âø¶õ, Á¹À½, À̸í(±Í¿ï¸²), ½Ã¾ßÈ帲, º¹½Ã(°ãº¸ÀÓ), ±¸Åä, ¿Â³Ã°¨, ¹«°¨°¢, ¿¬Ãà(¼öÃà°ú ÀÌ¿Ï), °æ·Ã, ÁøÀü(¶³¸²), ÀÇ½Ä ºÒ¸í, È£Èí¾ïÁ¦, È£ÈíÁ¤Áö)À̸ç, ´Ù¸¥ ¾Æ¹Ìµå ±¹¼Ò ¸¶ÃëÁ¦¿¡¼­ °üÂûµÇ´Â °Í°ú ºñ½ÁÇÏ´Ù. ÁßÃ߽Űæ°è ÈïºÐÀº ª°Ô ÀϾ°Å³ª ÀüÇô ÀϾÁö ¾ÊÀ» ¼ö ÀÖÀ¸¸ç, ÀÌ ¶§ Ãʱâ ¡ÈÄ·Î ±â¸é(Á¹À½)ÁõÀÌ ÀϾ°í ÀÇ½Ä ºÒ¸íÀ¸·Î ¹ßÀüÇÒ ¼ö ÀÖ´Ù. ½ÉÇ÷°ü°è ¡ÈÄ´Â ¼­¸Æ(´À¸°¸Æ), ÀúÇ÷¾Ð, ½ÉÇ÷°ü°è¼è¾à¿¡¼­ ½ÉÀå ¸¶ºñ·Î À̾îÁú ¼ö ÀÖ´Ù.

[Áï½Ã ¾Ë·Á¾ß ÇÏ´Â ÀÌ»ó¹ÝÀÀ]
»óÈ£ÀÛ¿ë

1) Ç׺ÎÁ¤¸Æ ¾à¹°: class 1 Ç׺ÎÁ¤¸Æ ¾à¹°(tocainide¿Í mexiletine µî)À» º¹¿ë ÁßÀΠȯÀÚ¿¡°Ô ÀÌ ¾àÀ» »ç¿ëÇÒ ¶§¿¡´Â µ¶¼ºÀÌ ºÎ°¡µÇ°Å³ª Áõ°¡µÉ °¡´É¼ºÀÌ Àֱ⠶§¹®¿¡ ÁÖÀÇÇØ¾ß ÇÑ´Ù.

2) ±¹¼Ò ¸¶ÃëÁ¦: ÀÌ ¾àÀ» ´Ù¸¥ ±¹¼Ò ¸¶ÃëÁ¦¸¦ ÇÔÀ¯ÇÑ ¾àÁ¦µé°ú µ¿½Ã¿¡ »ç¿ëÇÒ ¶§¿¡´Â, ¸ðµç Á¦Á¦·ÎºÎÅÍ Èí¼öµÇ´Â ÃÑ·®À» ¹Ýµå½Ã °í·ÁÇÏ¿©¾ß ÇÑ´Ù.

Related FDA Approved Drug
±âÁØ ¼ººÐ:LIDOCAINE
AKTEN (LIDOCAINE HYDROCHLORIDE)
ALPHACAINE (LIDOCAINE)
ALPHACAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
ANESTACON (LIDOCAINE HYDROCHLORIDE)
DECADRON W/ XYLOCAINE (DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE)
DENTIPATCH (LIDOCAINE)
DUOCAINE (BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE)
EMBOLEX (DIHYDROERGOTAMINE MESYLATE; HEPARIN SODIUM; LIDOCAINE HYDROCHLORIDE)
EMLA (LIDOCAINE; PRILOCAINE)
IONTOCAINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LANABIOTIC (BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
LARYNG-O-JET KIT (LIDOCAINE HYDROCHLORIDE)
LARYNGOTRACHEAL ANESTHESIA KIT (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE (LIDOCAINE)
LIDOCAINE AND PRILOCAINE (LIDOCAINE; PRILOCAINE)
LIDOCAINE AND TETRACAINE (LIDOCAINE; TETRACAINE)
LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE VISCOUS (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIDOCAINE VISCOUS (LIDOCAINE HYDROCHLORIDE)
LIDOCATON (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIDODERM (LIDOCAINE)
LIDOPEN (LIDOCAINE HYDROCHLORIDE)
LIDOSITE TOPICAL SYSTEM KIT (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIGNOSPAN FORTE (EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE)
LIGNOSPAN STANDARD (EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE)
LTA II KIT (LIDOCAINE HYDROCHLORIDE)
OCTOCAINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
ORAQIX (LIDOCAINE; PRILOCAINE)
PEDIATRIC LTA KIT (LIDOCAINE HYDROCHLORIDE)
ROCEPHIN KIT (CEFTRIAXONE SODIUM; LIDOCAINE)
SYNERA (LIDOCAINE; TETRACAINE)
TERRAMYCIN (LIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE)
XYLOCAINE (LIDOCAINE)
XYLOCAINE 1.5% W/ DEXTROSE 7.5% (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE 4% PRESERVATIVE FREE (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE 5% W/ GLUCOSE 7.5% (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE DENTAL (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE DENTAL WITH EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
XYLOCAINE PRESERVATIVE FREE (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE VISCOUS (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
ZINGO (LIDOCAINE HYDROCHLORIDE)
  • ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2025-09-30
  • º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
¾Ë¸²
»ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼­ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.

°æ°í
µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù. Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡±¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.

ÀüÈ­: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
About us |  Contact us |  FAQ |  Service ¾È³» |  ±¤°í ¹× Á¦È޾ȳ» |  °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ |  Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö |  SiteMap |  °í°´Áö¿ø